Characteristics of seroconversion and implications for diagnosis of post-treatment Lyme disease syndrome: acute and convalescent serology among a prospective cohort of early Lyme disease patients
[CanLyme note: Here is a quote from the Lyme Disease Research Foundation at John Hopkins University that furthers our long held concerns about the current two-tier testing model in use Canada-wide having very serious limitations as a diagnostic tool, “Characteristics of seroconversion and implications for diagnosis of post-treatment Lyme disease syndrome: acute and convalescent serology…